Delisting risk
ENvue Medical (FEED)
Electromagnetic feeding-tube navigation systems and therapeutic-ultrasound devices.
$4.07
Pre-market−0.05 (−1.21%)
At close$4.12(−4.41%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Gross profit | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | 2 | 3 | 4 | 5 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 3 | 5 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| General & administrative | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 3 | 2 | 0 |
| Operating income | −1 | −1 | −1 | −1 | −1 | −1 | −2 | −4 | −2 | −4 | −4 | −5 |
| 0 | 0 | 0 | 0 | 0 | 0 | −1 | 0 | 3 | −10 | 0 | 1 | |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | −3 | 3 | 0 | 0 |
| Income before tax | −1 | −1 | −1 | −1 | −1 | −1 | −2 | −4 | 1 | −13 | −4 | −5 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −1 | −1 | −1 | −1 | −1 | −1 | −2 | −4 | 1 | −13 | −4 | −5 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 |
| Net income | −1 | −1 | −1 | −1 | −1 | −1 | −2 | 0 | 1 | −13 | −4 | −5 |
| EPS, basic | −$46.47 | −$43.70 | −$25.77 | −$27.18 | −$469.92 | −$541.08 | −$477.60 | −$123.60 | −$10.92 | −$190.44 | −$82,532.04 | −$23.76 |
| EPS, diluted | −$46.47 | −$43.70 | −$25.77 | −$27.18 | −$469.92 | −$541.08 | −$477.60 | −$123.60 | −$10.92 | −$190.44 | −$82,532.04 | −$23.76 |
| Weighted average shares, basic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Weighted average shares, diluted | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| EBITDA | −1 | −1 | −1 | −1 | −1 | −1 | −2 | −3 | 1 | −7 | −4 | −5 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −1 | −1 | −1 | −1 | −1 | −1 | −2 | −4 | 1 | −7 | −4 | −5 |